Ekso Bionics Holdings Inc. announced Howard Palefsky, MBA, will join the board of directors for the company, according to a company press release.
“We are delighted to [add] Howard to our board. He has a proven track record of operational excellence and organizational development at medical device companies,” Thomas Looby, MBA, BS, president and chief executive officer of Ekso Bionics, said the release. “His experience and leadership will be vital as we continue growing.”
According to the release, Palefsky is an advisor or board member to multiple health care companies, including Olatec Therapeutics, Adigica Health, Life Sciences Alternative Funding and Victoria Capital Management. He previously served as a managing director at Montreux Equity Partners and was chairman and chief executive officer of the Montreux portfolio company, NeurogesX, the release noted. He also served as chairman, president and chief executive officer of Collagen Corporation.
“I am honored and delighted to be part of a company that can change lives the way that Ekso Bionics’ exoskeletons can and I am excited about the prospects for Ekso’s technologies to enable spinal cord injury and stroke patients to regain function,” Palefsky said in the release. “I look forward to working with management and the board to build on the great work already done as the company continues on its upward trajectory.”